XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Units
Incentive Units
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Series A Preferred Units
Series B Preferred Units
Beginning balance at Dec. 31, 2022               $ 28,971 $ 148,496
Beginning balance (in shares) at Dec. 31, 2022               20,000,000 45,089,212
Ending balance at Mar. 31, 2023               $ 28,971 $ 148,496
Ending balance (in shares) at Mar. 31, 2023               20,000,000 45,089,212
Beginning balance at Dec. 31, 2022 $ (35,392) $ 2,251 $ 2,142     $ (39,785)      
Beginning balance (in shares) at Dec. 31, 2022   5,000,000 1,625,086            
MEMBERS' DEFICIT                  
Equity Based Compensation Expense 1,274   $ 1,274            
Net loss (12,525)         (12,525)      
Ending balance at Mar. 31, 2023 $ (46,643) $ 2,251 $ 3,416     (52,310)      
Ending balance (in shares) at Mar. 31, 2023   5,000,000 1,625,086            
Beginning balance at Dec. 31, 2022               $ 28,971 $ 148,496
Beginning balance (in shares) at Dec. 31, 2022               20,000,000 45,089,212
Ending balance at Jun. 30, 2023               $ 28,971 $ 148,496
Ending balance (in shares) at Jun. 30, 2023 65,089,212             20,000,000 45,089,212
Beginning balance at Dec. 31, 2022 $ (35,392) $ 2,251 $ 2,142     (39,785)      
Beginning balance (in shares) at Dec. 31, 2022   5,000,000 1,625,086            
MEMBERS' DEFICIT                  
Net loss (31,410)                
Ending balance at Jun. 30, 2023 $ (64,415) $ 2,251 $ 4,529     (71,195)      
Ending balance (in shares) at Jun. 30, 2023   5,000,000 2,481,543            
Beginning balance at Mar. 31, 2023               $ 28,971 $ 148,496
Beginning balance (in shares) at Mar. 31, 2023               20,000,000 45,089,212
Ending balance at Jun. 30, 2023               $ 28,971 $ 148,496
Ending balance (in shares) at Jun. 30, 2023 65,089,212             20,000,000 45,089,212
Beginning balance at Mar. 31, 2023 $ (46,643) $ 2,251 $ 3,416     (52,310)      
Beginning balance (in shares) at Mar. 31, 2023   5,000,000 1,625,086            
MEMBERS' DEFICIT                  
Issuance of common stock upon exercise of stock options (in shares)     856,457            
Equity Based Compensation Expense 1,113   $ 1,113            
Net loss (18,885)         (18,885)      
Ending balance at Jun. 30, 2023 (64,415) $ 2,251 $ 4,529     (71,195)      
Ending balance (in shares) at Jun. 30, 2023   5,000,000 2,481,543            
Beginning balance at Dec. 31, 2023 379,913       $ 503,354 (123,770) $ 329    
Beginning balance (in shares) at Dec. 31, 2023       48,338,769          
MEMBERS' DEFICIT                  
Common stock issued, net of issuance costs of $33,045 449,955     $ 1 449,954        
Common stock issued, net of issuance costs of $33,045 (in shares)       7,790,321          
Vesting of restricted stock (in shares)       237,665          
Issuance of common stock upon exercise of stock options 24       24        
Issuance of common stock upon exercise of stock options (in shares)       1,047          
Equity Based Compensation Expense 4,186       4,186        
Change in unrealized loss on marketable securities, net of tax (506)           (506)    
Net loss (32,094)         (32,094)      
Ending balance at Mar. 31, 2024 801,478     $ 1 957,518 (155,864) (177)    
Ending balance (in shares) at Mar. 31, 2024       56,367,802          
Beginning balance at Dec. 31, 2023 $ 379,913       503,354 (123,770) 329    
Beginning balance (in shares) at Dec. 31, 2023       48,338,769          
MEMBERS' DEFICIT                  
Issuance of common stock upon exercise of stock options (in shares) 1,675                
Change in unrealized loss on marketable securities, net of tax $ (618)                
Net loss (65,910)                
Ending balance at Jun. 30, 2024 773,639     $ 1 963,607 (189,680) (289)    
Ending balance (in shares) at Jun. 30, 2024       56,676,465          
Beginning balance at Mar. 31, 2024 801,478     $ 1 957,518 (155,864) (177)    
Beginning balance (in shares) at Mar. 31, 2024       56,367,802          
MEMBERS' DEFICIT                  
Vesting of restricted stock (in shares)       292,477          
Issuance of common stock upon exercise of stock options 14       14        
Issuance of common stock upon exercise of stock options (in shares)       628          
Issuance of common stock under employee stock purchase plan 377       377        
Issuance of common stock under employee stock purchase plan (in shares)       15,558          
Equity Based Compensation Expense 5,698       5,698        
Change in unrealized loss on marketable securities, net of tax (112)           (112)    
Net loss (33,816)         (33,816)      
Ending balance at Jun. 30, 2024 $ 773,639     $ 1 $ 963,607 $ (189,680) $ (289)    
Ending balance (in shares) at Jun. 30, 2024       56,676,465